Tune Therapeutics jobs and careers
Durham, NC, United States
About Tune Therapeutics
With its versatile and powerful TEMPO epigenomic control platform, Tune Therapeutics is pioneering a new therapeutic modality that can fine-tune any gene network and unlock the full power and potential of regenerative medicine. With deep experience and a passionate commitment to exploration and innovation, Tune is driving through an inflection point in the history of genetic medicine: from targeting a limited range of rare conditions, to addressing thousands of common and complex diseases for which no curative treatment is available.
Founded in 2020 by Akira Matsuno, Charles Gersbach and Fyodor Urnov.
- Founded
- 2020
- Employees
- 125
- Total funding
- $40M
- Headquarters
- Durham
Leadership
The top of Tune Therapeutics's org chart, with how many people report into each leader.
Derek Jantz
CSO
24 reports
Tyler Goodwin
Head of Delivery Technologies and Development
2 reports
Luis Sanchez-Perez
Director Of Preclinical Translation
1 report
Kendra Congdon
Senior Director, Program Lead
1 report
Georgeta Puscalau
Senior Vice President Quality
1 report
Jason Dean
Head Of Bioinformatics
1 report
Charles A. Gersbach
Co-Founder, Acting CSO
Zachary Hale
EVP, General Counsel
Michael P. Hefferan
Director And Head Of In Vivo Pharmacology
Christina Jordan
Senior Director, Intellectual Property
Glenn Murphy
Director Of Communications
Blythe Sather
VP & Head, Research
23 reports
Emi Tokuda
Senior Scientist
Haley Peper
Senior Project Manager
Nicole DeNamur
Associate Scientist
Kiran Sangaru
HR Manager
Greg Bond
Assocuate Director
Erica Li
Senior Bioinformatics Analyst
Board
John McHutchison
Director
Fyodor Urnov
Co-Founder, Scientific Advisor
Dan McHugh
Director
Ali Behbahani
Director
Christina Trojel-Hansen
Co-founder And Founding CEO
Jobs at Tune Therapeutics
No open positions right now. Explore more companies on TheJobsMap.